Modeling & Simulation Exercise to Recommend Dosage Regimens for Patients with End-Stage Renal Disease Receiving Hemodialysis
Thursday 16 October, 2025
Objectives: End-stage-renal-disease (ESRD) is a condition when kidney does not adequately excrete wastes via urine to regulate hormones and chemicals…
Read more
Population Pharmacokinetic Analysis To Support Dosing Regimens Of Ceftobiprole
Thursday 16 October, 2025
Objectives: Ceftobiprole is a first-in-class broad-spectrum cephalosporin with activity against methicillin-resistant staphylococci. Dosage adjustment strategy was supported by a population…
Read more
Development and application of a population pharmacokinetic model of TMC114 in healthy volunteers and HIV-1 infected subjects after administration of TMC114 in combination with low dose ritonavir
Thursday 16 October, 2025
TMC114 is a HIV protease inhibitor (PI) that is potent against wild-type and PI-resistant human immunodeficiency virus. TMC114 is administered…
Read more